Nisoldipine

CAS No. 63675-72-9

Nisoldipine( BAY-k 5552 )

Catalog No. M15415 CAS No. 63675-72-9

A dihydropyridine type calcium channel blocker that is used as an antihypertensive.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 37 In Stock
500MG 52 In Stock
1G 85 In Stock

Biological Information

  • Product Name
    Nisoldipine
  • Note
    Research use only, not for human use.
  • Brief Description
    A dihydropyridine type calcium channel blocker that is used as an antihypertensive.
  • Description
    A dihydropyridine type calcium channel blocker that is used as an antihypertensive.Hypertension Approved.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BAY-k 5552
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    L-typeCav1.2
  • Research Area
    Cardiovascular Disease
  • Indication
    Hypertension

Chemical Information

  • CAS Number
    63675-72-9
  • Formula Weight
    388.4144
  • Molecular Formula
    C20H24N2O6
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
  • Chemical Name
    3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, 3-methyl 5-(2-methylpropyl) ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hamilton SF, et al. Heart Dis. 1999 Nov-Dec;1(5):279-88. 2. Duncker DJ, et al. Br J Pharmacol. 1986 May;88(1):9-18. 3. De Jong JW, et al. Br J Pharmacol. 1984 Dec;83(4):943-9.
molnova catalog
related products
  • PD0176078

    PD0176078 is a newly blocker of N-type Calcium channel.

  • 2,3-Dihydroxy-4-meth...

    2,3-Dihydroxy-4-methoxyacetophenone is a natural product,it improves cognitive function and may be helpful for the treatment of Alzheimer's disease.

  • MMK 1

    Potent and selective human formyl peptide receptor FPR2 agonist (EC50 values are 1, 2 and > 10 000 nM at mFRP2, hFPR2 and hFPR1 respectively). Induces migration of human monocytes and neutrophils via a chemotactic mechanism and enhances production of proinflammatory cytokines IL-1β and IL-6. Also activates the neutrophil superoxide-generating NADPH-oxidase.